{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:52:23Z","timestamp":1791183143153,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T00:00:00Z","timestamp":1417996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/nm.3759","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T17:52:43Z","timestamp":1418061163000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":84,"title":["Chemical corrector treatment ameliorates increased seizure susceptibility in a mouse model of familial epilepsy"],"prefix":"10.1038","volume":"21","author":[{"given":"Norihiko","family":"Yokoi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Fukata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taisuke","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Jaegle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshika","family":"Ohkawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Iwanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Mochizuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Hamakubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Imoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dies","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Fukata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,8]]},"reference":[{"key":"BFnm3759_CR1","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/ana.10280","volume":"52","author":"W Gu","year":"2002","unstructured":"Gu, W., Brodtkorb, E. & Steinlein, O.K. LGI1 is mutated in familial temporal lobe epilepsy characterized by aphasic seizures. Ann. Neurol. 52, 364\u2013367 (2002).","journal-title":"Ann. Neurol."},{"key":"BFnm3759_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/ng832","volume":"30","author":"S Kalachikov","year":"2002","unstructured":"Kalachikov, S. et al. Mutations in LGI1 cause autosomal-dominant partial epilepsy with auditory features. Nat. Genet. 30, 335\u2013341 (2002).","journal-title":"Nat. Genet."},{"key":"BFnm3759_CR3","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1093\/hmg\/11.9.1119","volume":"11","author":"JM Morante-Redolat","year":"2002","unstructured":"Morante-Redolat, J.M. et al. Mutations in the LGI1\/Epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum. Mol. Genet. 11, 1119\u20131128 (2002).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm3759_CR4","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani, S.R. et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 133, 2734\u20132748 (2010).","journal-title":"Brain"},{"key":"BFnm3759_CR5","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","volume":"9","author":"M Lai","year":"2010","unstructured":"Lai, M. et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol. 9, 776\u2013785 (2010).","journal-title":"Lancet Neurol."},{"key":"BFnm3759_CR6","doi-asserted-by":"publisher","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","volume":"33","author":"T Ohkawa","year":"2013","unstructured":"Ohkawa, T. et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J. Neurosci. 33, 18161\u201318174 (2013).","journal-title":"J. Neurosci."},{"key":"BFnm3759_CR7","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1093\/brain\/awq171","volume":"133","author":"E Chabrol","year":"2010","unstructured":"Chabrol, E. et al. Electroclinical characterization of epileptic seizures in leucine-rich, glioma-inactivated 1-deficient mice. Brain 133, 2749\u20132762 (2010).","journal-title":"Brain"},{"key":"BFnm3759_CR8","doi-asserted-by":"publisher","first-page":"3799","DOI":"10.1073\/pnas.0914537107","volume":"107","author":"Y Fukata","year":"2010","unstructured":"Fukata, Y. et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc. Natl. Acad. Sci. USA 107, 3799\u20133804 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3759_CR9","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1093\/hmg\/ddq047","volume":"19","author":"YE Yu","year":"2010","unstructured":"Yu, Y.E. et al. Lgi1 null mutant mice exhibit myoclonic seizures and CA1 neuronal hyperexcitability. Hum. Mol. Genet. 19, 1702\u20131711 (2010).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm3759_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.neuron.2006.01.033","volume":"49","author":"U Schulte","year":"2006","unstructured":"Schulte, U. et al. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvbeta1. Neuron 49, 697\u2013706 (2006).","journal-title":"Neuron"},{"key":"BFnm3759_CR11","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1126\/science.1129947","volume":"313","author":"Y Fukata","year":"2006","unstructured":"Fukata, Y. et al. Epilepsy-related ligand\/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 313, 1792\u20131795 (2006).","journal-title":"Science"},{"key":"BFnm3759_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2202-6-33","volume":"6","author":"K Sagane","year":"2005","unstructured":"Sagane, K. et al. Ataxia and peripheral nerve hypomyelination in ADAM22-deficient mice. BMC Neurosci. 6, 33 (2005).","journal-title":"BMC Neurosci."},{"key":"BFnm3759_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.mcn.2009.09.008","volume":"42","author":"K Owuor","year":"2009","unstructured":"Owuor, K. et al. LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology. Mol. Cell. Neurosci. 42, 448\u2013457 (2009).","journal-title":"Mol. Cell. Neurosci."},{"key":"BFnm3759_CR14","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1038\/nm.2019","volume":"15","author":"YD Zhou","year":"2009","unstructured":"Zhou, Y.D. et al. Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Nat. Med. 15, 1208\u20131214 (2009).","journal-title":"Nat. Med."},{"key":"BFnm3759_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/humu.20925","volume":"30","author":"C Nobile","year":"2009","unstructured":"Nobile, C. et al. LGI1 mutations in autosomal dominant and sporadic lateral temporal epilepsy. Hum. Mutat. 30, 530\u2013536 (2009).","journal-title":"Hum. Mutat."},{"key":"BFnm3759_CR16","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1093\/hmg\/ddi169","volume":"14","author":"KR Senechal","year":"2005","unstructured":"Senechal, K.R., Thaller, C. & Noebels, J.L. ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy. Hum. Mol. Genet. 14, 1613\u20131620 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm3759_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1212\/WNL.0b013e318212ab2e","volume":"76","author":"P Striano","year":"2011","unstructured":"Striano, P. et al. Familial temporal lobe epilepsy with psychic auras associated with a novel LGI1 mutation. Neurology 76, 1173\u20131176 (2011).","journal-title":"Neurology"},{"key":"BFnm3759_CR18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1212\/WNL.0b013e318247ccbf","volume":"78","author":"YY Ho","year":"2012","unstructured":"Ho, Y.Y., Ionita-Laza, I. & Ottman, R. Domain-dependent clustering and genotype-phenotype analysis of LGI1 mutations in ADPEAF. Neurology 78, 563\u2013568 (2012).","journal-title":"Neurology"},{"key":"BFnm3759_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.molcel.2007.05.032","volume":"27","author":"T Sold\u00e0","year":"2007","unstructured":"Sold\u00e0, T., Galli, C., Kaufman, R.J. & Molinari, M. Substrate-specific requirements for UGT1-dependent release from calnexin. Mol. Cell 27, 238\u2013249 (2007).","journal-title":"Mol. Cell"},{"key":"BFnm3759_CR20","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/bies.200800186","volume":"31","author":"B Honor\u00e9","year":"2009","unstructured":"Honor\u00e9, B. The rapidly expanding CREC protein family: members, localization, function, and role in disease. BioEssays 31, 262\u2013277 (2009).","journal-title":"BioEssays"},{"key":"BFnm3759_CR21","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1093\/hmg\/ddl421","volume":"15","author":"MS Sirerol-Piquer","year":"2006","unstructured":"Sirerol-Piquer, M.S. et al. The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface. Hum. Mol. Genet. 15, 3436\u20133445 (2006).","journal-title":"Hum. Mol. Genet."},{"key":"BFnm3759_CR22","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1523\/JNEUROSCI.6287-09.2010","volume":"30","author":"E Ozkaynak","year":"2010","unstructured":"Ozkaynak, E. et al. Adam22 is a major neuronal receptor for Lgi4-mediated Schwann cell signaling. J. Neurosci. 30, 3857\u20133864 (2010).","journal-title":"J. Neurosci."},{"key":"BFnm3759_CR23","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1242\/dev.107995","volume":"141","author":"L Kegel","year":"2014","unstructured":"Kegel, L. et al. Functional phylogenetic analysis of LGI proteins identifies an interaction motif crucial for myelination. Development 141, 1749\u20131756 (2014).","journal-title":"Development"},{"key":"BFnm3759_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1083\/jcb.201208083","volume":"199","author":"T Okiyoneda","year":"2012","unstructured":"Okiyoneda, T. & Lukacs, G.L. Fixing cystic fibrosis by correcting CFTR domain assembly. J. Cell Biol. 199, 199\u2013204 (2012).","journal-title":"J. Cell Biol."},{"key":"BFnm3759_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/0092-8674(95)90240-6","volume":"83","author":"CL Ward","year":"1995","unstructured":"Ward, C.L., Omura, S. & Kopito, R.R. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83, 121\u2013127 (1995).","journal-title":"Cell"},{"key":"BFnm3759_CR26","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1172\/JCI119788","volume":"100","author":"RC Rubenstein","year":"1997","unstructured":"Rubenstein, R.C., Egan, M.E. & Zeitlin, P.L. In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. J. Clin. Invest. 100, 2457\u20132465 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFnm3759_CR27","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nchembio.275","volume":"6","author":"DM Hutt","year":"2010","unstructured":"Hutt, D.M. et al. Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis. Nat. Chem. Biol. 6, 25\u201333 (2010).","journal-title":"Nat. Chem. Biol."},{"key":"BFnm3759_CR28","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cell.2008.06.037","volume":"134","author":"TW Mu","year":"2008","unstructured":"Mu, T.W. et al. Chemical and biological approaches synergize to ameliorate protein-folding diseases. Cell 134, 769\u2013781 (2008).","journal-title":"Cell"},{"key":"BFnm3759_CR29","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1126\/science.1128294","volume":"313","author":"U Ozcan","year":"2006","unstructured":"Ozcan, U. et al. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313, 1137\u20131140 (2006).","journal-title":"Science"},{"key":"BFnm3759_CR30","doi-asserted-by":"publisher","first-page":"E207","DOI":"10.1038\/35041139","volume":"2","author":"RR Kopito","year":"2000","unstructured":"Kopito, R.R. & Ron, D. Conformational disease. Nat. Cell Biol. 2, E207\u2013E209 (2000).","journal-title":"Nat. Cell Biol."},{"key":"BFnm3759_CR31","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1172\/JCI58183","volume":"121","author":"GS Zode","year":"2011","unstructured":"Zode, G.S. et al. Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma. J. Clin. Invest. 121, 3542\u20133553 (2011).","journal-title":"J. Clin. Invest."},{"key":"BFnm3759_CR32","doi-asserted-by":"publisher","first-page":"21200","DOI":"10.1073\/pnas.1119181109","volume":"108","author":"J Lu","year":"2011","unstructured":"Lu, J. et al. Histone deacetylase inhibitors prevent the degradation and restore the activity of glucocerebrosidase in Gaucher disease. Proc. Natl. Acad. Sci. USA 108, 21200\u201321205 (2011).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3759_CR33","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.celrep.2012.12.007","volume":"3","author":"C Yang","year":"2013","unstructured":"Yang, C., Huntoon, K., Ksendzovsky, A., Zhuang, Z. & Lonser, R.R. Proteostasis modulators prolong missense VHL protein activity and halt tumor progression. Cell Reports 3, 52\u201359 (2013).","journal-title":"Cell Reports"},{"key":"BFnm3759_CR34","doi-asserted-by":"publisher","first-page":"12999","DOI":"10.1073\/pnas.0700163104","volume":"104","author":"MJ Gallagher","year":"2007","unstructured":"Gallagher, M.J., Ding, L., Maheshwari, A. & Macdonald, R.L. The GABAA receptor alpha1 subunit epilepsy mutation A322D inhibits transmembrane helix formation and causes proteasomal degradation. Proc. Natl. Acad. Sci. USA 104, 12999\u201313004 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3759_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2165\/11591280-000000000-00000","volume":"11","author":"T Iannitti","year":"2011","unstructured":"Iannitti, T. & Palmieri, B. Clinical and experimental applications of sodium phenylbutyrate. Drugs R D. 11, 227\u2013249 (2011).","journal-title":"Drugs R D."},{"key":"BFnm3759_CR36","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1124\/mol.105.010959","volume":"67","author":"N Pedemonte","year":"2005","unstructured":"Pedemonte, N. et al. Phenylglycine and sulfonamide correctors of defective F508 and G551D cystic fibrosis transmembrane conductance regulator chloride-channel gating. Mol. Pharmacol. 67, 1797\u20131807 (2005).","journal-title":"Mol. Pharmacol."},{"key":"BFnm3759_CR37","doi-asserted-by":"publisher","first-page":"18825","DOI":"10.1073\/pnas.0904709106","volume":"106","author":"F Van Goor","year":"2009","unstructured":"Van Goor, F. et al. Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc. Natl. Acad. Sci. USA 106, 18825\u201318830 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3759_CR38","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1212\/01.wnl.0000323926.77565.ee","volume":"71","author":"MJ Rosanoff","year":"2008","unstructured":"Rosanoff, M.J. & Ottman, R. Penetrance of LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 71, 567\u2013571 (2008).","journal-title":"Neurology"},{"key":"BFnm3759_CR39","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1111\/j.1460-9568.2010.07254.x","volume":"31","author":"M Yamazaki","year":"2010","unstructured":"Yamazaki, M. et al. TARPs gamma-2 and gamma-7 are essential for AMPA receptor expression in the cerebellum. Eur. J. Neurosci. 31, 2204\u20132220 (2010).","journal-title":"Eur. J. Neurosci."},{"key":"BFnm3759_CR40","doi-asserted-by":"publisher","first-page":"24552","DOI":"10.1074\/jbc.M302801200","volume":"278","author":"K Masuda","year":"2003","unstructured":"Masuda, K. et al. A combinatorial G protein-coupled receptor reconstitution system on budded baculovirus. Evidence for G alpha(i) and G alpha(o) coupling to a human leukotriene B4 receptor. J. Biol. Chem. 278, 24552\u201324562 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnm3759_CR41","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jim.2007.02.005","volume":"322","author":"R Saitoh","year":"2007","unstructured":"Saitoh, R. et al. Viral envelope protein gp64 transgenic mouse facilitates the generation of monoclonal antibodies against exogenous membrane proteins displayed on baculovirus. J. Immunol. Methods 322, 104\u2013117 (2007).","journal-title":"J. Immunol. Methods"},{"key":"BFnm3759_CR42","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1523\/JNEUROSCI.17-12-04688.1997","volume":"17","author":"A L\u00fcthi","year":"1997","unstructured":"L\u00fcthi, A. et al. Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation. J. Neurosci. 17, 4688\u20134699 (1997).","journal-title":"J. Neurosci."},{"key":"BFnm3759_CR43","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1046\/j.1460-9568.1998.00063.x","volume":"10","author":"M Watanabe","year":"1998","unstructured":"Watanabe, M. et al. Selective scarcity of NMDA receptor channel subunits in the stratum lucidum (mossy fibre-recipient layer) of the mouse hippocampal CA3 subfield. Eur. J. Neurosci. 10, 478\u2013487 (1998).","journal-title":"Eur. J. Neurosci."},{"key":"BFnm3759_CR44","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1083\/jcb.200903101","volume":"186","author":"J Noritake","year":"2009","unstructured":"Noritake, J. et al. Mobile DHHC palmitoylating enzyme mediates activity-sensitive synaptic targeting of PSD-95. J. Cell Biol. 186, 147\u2013160 (2009).","journal-title":"J. Cell Biol."},{"key":"BFnm3759_CR45","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3758\/BF03193146","volume":"39","author":"F Faul","year":"2007","unstructured":"Faul, F., Erdfelder, E., Lang, A.G. & Buchner, A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39, 175\u2013191 (2007).","journal-title":"Behav. Res. Methods"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3759.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3759","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3759.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T22:48:50Z","timestamp":1684450130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,8]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFnm3759"],"URL":"https:\/\/doi.org\/10.1038\/nm.3759","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,8]]},"assertion":[{"value":"20 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}